simfibrate has been researched along with azathioprine in 1 studies
*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]
*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y | 1 |
1 other study(ies) available for simfibrate and azathioprine
Article | Year |
---|---|
The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats.
Topics: Animals; Anticholesteremic Agents; Azathioprine; CD4-Positive T-Lymphocytes; Cholestyramine Resin; Clofibrate; Cyclosporine; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Glomerulus; Leukocytes, Mononuclear; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-2 | 1996 |